Nussbaum Law Group, P.C. and Roberts Law Firm US, PC Announce A $50 Million Class Action Settlement with Pfizer on Behalf of Direct Purchasers of EpiPen® or Generic EpiPen
and Roberts Law Firm US, PC:
- and Roberts Law Firm US, PC:
If you purchased EpiPen® or generic EpiPen directly from the manufacturer, you may receive a payment from a $50 million class action settlement with Pfizer. - A proposed settlement (“Settlement”) has been reached in a class action lawsuit with Pfizer, Inc., Meridian Medical Technologies, Inc., and King Pharmaceuticals, Inc. (n/k/a King Pharmaceuticals LLC) (together, “Pfizer”).
- Under the settlement, Pfizer agreed to pay $50,000,000 into a settlement fund for the Direct Purchaser Settlement Class (“Settlement Fund”).
- The settlement does not resolve claims against Mylan, and the lawsuit against Mylan will continue until it is resolved.